Miltefosine CAS 58066-85-6
Miltefosine CAS 58066-85-6
20 5 月, 20201-Methylimidazole CAS 616-47-7
20 5 月, 2020
Miltefosine typical Properties
| TEST ITEMS | SPECIFICATIONS |
| Appearance | Off-white to white powder |
| Identification(byMS,IR,1H-N MR,13C-NMR,31P-NMR) | Corresponds to structure |
| Water(K.F.) | NMT5.0% |
| PH of 1% solution in water | Between 4.0~8.0 |
| Clarity (1.0% in H2O; 1.0%inMethanol) | Clear and colorless solution |
| Related substance(TLC) Choline ChlorideOther Individual Impurity Total Impurity | NMT 1.0%NMT 1.0%NMT 2.0% |
| Assay(HCIO4) | 98.0%~102% |
Miltefosine Usage
- Metifoxin can enter the cell membrane and block the cell signaling process to induce a special functional disorder to prevent the tumor from further growth, and has immunoregulatory activity, can promote IL-2 mediated T cell activation, the hormone Breast-dependent breast cancer can produce a strong inhibitory effect and is inactive against hormone-independent cell line tumors.
- Metifoxin is used for palliative treatment of breast cancer skin that is difficult to be treated by conventional treatment.
- Metifoxin was originally developed as an anti-tumor drug, an alkyl phosphate choline drug, with cell membrane targeting, showing significant selective anti-tumor and antiprotozoal activity in animal experiments and clinical applications .
Miltefosine Packaging and Shipping
Packing: foil Aluminium bag
Delivery:By Express, by sea,by air.